ARS Pharmaceuticals Showcases Intranasal Epinephrine Data at 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
Here's Why We're Not At All Concerned With ARS Pharmaceuticals' (NASDAQ:SPRY) Cash Burn Situation
Form 144 | ARS Pharmaceuticals(SPRY.US) Officer Proposes to Sell 4.2 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 15, $ARS Pharmaceuticals(SPRY.US)$ Officer Tanimoto Sarina intends to sell 300K shares of its common stock on Oct 15, with a total market value of approximately $4.2
Express News | ARS Pharmaceuticals Inc - as Partial Consideration for Deal, Co Obligated to Pay Nuova Upfront Payment of Three Mln Euros
Express News | ARS Pharmaceuticals- Unit Entered Supply Agreement With Nuova Ompi S.r.l.
Jasper Gains 11% on Data for Briquilimab in Urticaria